Sidley advised on the initial public offering (IPO) and H share listing of Wuhan Dazhong Dental Medical Co., Ltd. (HKEX: 2651, Dazhong Dental) on the Main Board of the Hong Kong Stock Exchange (HKEX). Sidley acted as Hong Kong counsel for the sole sponsor Haitong International Capital Limited, and the underwriters.
Dazhong Dental is a private dental services provider in Central China with a focus on Hubei and Hunan provinces, operating an expanding dental service network under a direct chain model.
The Sidley team was led by partners Claudia Yu and Meng Ding. Other team members included China Advisor Anna Ding, managing associates Cindy Liu and Yiming Chen, senior corporate manager Hannah Wong, senior legal assistant Sia Yang, and legal assistant Andy Tam.
Sidley has been a market leader in advising life sciences and biotech IPOs in Hong Kong. Notably, it is the only Band One firm ranked by Chambers Greater China Region/APAC in life sciences for 16 consecutive years. Sidley has also been “highly recommended” in “Innovative Lawyers in Unlock Capital” by the FT Innovative Lawyers APAC Awards in May this year, recognizing its contribution in “Reformed Listing Rules on the HKEX – revitalizing the Hong Kong IPO market.” Additionally, Sidley’s Capital Markets practice has also received a number of independent recognitions from publications such as The Asia Legal Awards by Law.com International, IFLR APAC Awards, China Business Law Journal and Legal 500 APAC.
